Skip to main content

Table 3 Pearson’s correlation matrix of the descriptors in the selected model

From: In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line

 

AATSC8c

MATS8c

SpMAD_Dzs

BCUTc-1 l

AATSC8c

1

   

MATS8c

0.989573

1

  

SpMAD_Dzs

0.194418

0.168297

1

 

BCUTc-1l

− 0.1423

-0.12496

0.000392

1